Skip to main content
letter
. 2007 Oct;56(10):1470–1471. doi: 10.1136/gut.2007.128777

Table 1 Epidemiological and clinical data of the case study.

HBsAG− HBsAG+
Anti‐HBc+ Anti‐HBc+ Anti‐HBc−
Anti‐HBs+
Number 18 3 31 6
Age (years) (range) 58 (51 to 70) 52 (46 to 73) 44 (28 to 71) 53 (47 to 70)
Sex (M/F) 8/10 2/1 11/20 4/2
HCV 8 7
Lymphoma grading low/intermediate/high 8/6/4 0/2/1 10/11/10 3/1/1/1 maltoma
Previous treatment with lamivudine 6

HCV, hepatitis C virus.